Alcyone Therapeutics

Alcyone Therapeutics

Private
Lowell, MassachusettsHealthcare & Life Scienceswww.alcyonetx.com

Last Round

Strategic

Apr 24, 2025

Total Funding Raised

$9.32M

Momentum Score

25 /100

Company Overview

Alcyone Therapeutics is a biotechnology company specializing in neural intervention technology aimed at treating neurological conditions through targeted drug therapy and hydrocephalus solutions.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Precision Medicine, Clinical Trials, Drug Discovery

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

intrathecal drug deliverygene therapyimplantable medical deviceCNS drug deliverypediatric neurological disordersdrug delivery devicelumbar puncture alternativespinal tap alternativecerebrospinal fluid accessCSF accessclinical-stage biotechrare disease therapyBatten disease therapyRett Syndrome therapyASO therapysubcutaneous portBreakthrough Device Designation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Alcyone Therapeutics Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Alcyone Therapeutics Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
StrategicApr 24, 2025
VC RoundJan 8, 2025
VC RoundJun 17, 2021
GrantDec 8, 2020
Early FundingAug 21, 2020
Series B
Jan 15, 2014

Alcyone Therapeutics Investors

Notable investors and investment history

InvestorRounds
MPM CapitalSeries A
NASAGrant
Harbor Light Capital PartnersSeries A, Series B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 17, 2025

    ThecaFlex product received designation from the U.S. Food and Drug Administration.

Alcyone Therapeutics Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Alcyone Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Alcyone Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersLowell, Massachusetts
Employee Range12
Year Founded2010
Last FundingApr 24, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.